Does GEHA Cover Zepbound? Yes, but Only With a Formulary Exception (2026)

Does GEHA cover Zepbound? Yes, for weight loss through an approved formulary exception under its 2026 FEHB rules. Zepbound is non-formulary on all five plans. Approval does not tell you the price: confirm the rate for your prescription before paying. Medicare prescription benefits need a separate check. 1

By The RX Index Editorial Team · Last verified September 22, 2026 · How we checked this

The RX Index — independent guidance for choosing your GLP-1 path.

Affiliate disclosure: Some links on this page are affiliate links, marked "sponsored." We may earn a commission if you start care through them. That never changes what GEHA's rules say, or which option is cheapest for you.

Here's the part that can catch you at the pharmacy counter: getting approved is only half the question. An approved prescription can still cost more than paying cash. We did the math below using GEHA's published plan rates and Lilly's self-pay prices—and marked where your own quote is needed.

Compare GEHA plan rates with cash prices ↓

Three things change your answer:

• Your plan. On Elevate, non-preferred brand drugs cost 100%, and there's no mail order. That does not establish how an approved Zepbound exception would be priced. 9
• Your Wegovy history. Caremark's public exception template asks about it. Confirm that GEHA uses that rule for your request before assuming you must try Wegovy. 3
• Your Medicare status. If your drugs run through a Medicare Part D plan, different rules apply. Medicare coordination can also change your GEHA costs. 10 28

Were you on Zepbound through GEHA High, Standard, or HDHP last year? You didn't do anything wrong. GEHA changed Zepbound from preferred to non-formulary on January 1, 2026. 1

Does GEHA cover Zepbound in 2026?

For weight loss, GEHA lists Zepbound as non-formulary on all five of its FEHB plans (High, Standard, HDHP, Elevate Plus, and Elevate), so a prescription alone is not enough. An approved formulary exception is required. In 2025, Zepbound was a preferred drug with prior authorization on High, Standard, and HDHP. 1

Source: GEHA, “Pharmacy coverage for weight loss GLP-1 medications”, document FE-WEB-1225-001, checked September 22, 2026. This is the regular FEHB weight-loss benefit, not a Medicare coverage decision.

Three words, in plain English:

• Formulary is GEHA's list of drugs it normally pays for.
• Non-formulary means Zepbound isn't on that list.
• Formulary exception means asking the plan to cover a drug outside that list based on your medical need. Prior authorization checks whether you meet the coverage rules. An exception request can still involve that medical review; the two are not interchangeable. 2 3 4

Postal (PSHB) members: GEHA's FAQ lists only the five FEHB plans. Your plans use a separate cost tool, so check Zepbound there before you assume anything. Check PSHB drug costs.

Why do so many people fight for Zepbound instead of taking Wegovy? In the SURMOUNT-5 trial, 751 adults without type 2 diabetes were assigned to Zepbound or Wegovy for a 72-week comparison. People on Zepbound lost 20.2% of their body weight on average, compared with 13.7% on Wegovy (New England Journal of Medicine, 2025). That's an average from a study, not a promise for any one person. Both medicines worked for many people. The trial compared weekly tirzepatide at the maximum tolerated 10 mg or 15 mg dose with semaglutide at 1.7 mg or 2.4 mg; Eli Lilly funded it. It does not compare every dose or newer formulation. 29

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, your treatment needs, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to explore a provider match before you choose. Confirm your own Zepbound coverage and price with GEHA separately.

Why does GEHA's drug cost tool say Zepbound is covered?

GEHA's Check Drug Costs tool lists Zepbound because Zepbound can be covered for members who already have an approved formulary exception. GEHA explains this in its own FAQ. A price in the tool is an estimate, not an approval. 1 5

This trips up a lot of members. GEHA had to answer it in writing: its FAQ asks, in its own words, why the tool shows Zepbound as covered when it's non-formulary. The answer is that Zepbound is still covered for members with an approved exception.

So "Does GEHA cover Zepbound?" is really three separate questions. We call them the 3 checks:

Two tips for the cost tool:

1. Read any Plan Notes and approval requirements alongside the result. A displayed price does not remove an exception requirement.
2. On HDHP, the price shown is what you pay after you've met your deductible. GEHA says so on the tool's page. 5

Here's the exact question to ask when you call:

"Is there an active approval on file for my Zepbound prescription, or is the price I'm seeing only an estimate?"

What does GEHA need to approve Zepbound?

Your doctor needs the rules for your exact GEHA benefit and records supporting the request. Caremark's public Zepbound exception template asks whether Wegovy failed, caused intolerable side effects, or is medically unsuitable. We did not find a GEHA document confirming that this exact template governs every GEHA request. 2 3

That is not a reason to guess. Call 1-844-443-4279 and ask for the current Zepbound formulary-exception criteria and any separate clinical prior-authorization criteria for your plan and treatment purpose.

We call this the approval ladder. You climb it one step at a time:

Which of these four people are you?

This table is a preparation guide, not an estimate of your approval odds. Whether Wegovy is right for you is a medical decision for you and your doctor. Never take a drug just to check a box.

You're not the only one going through this. On Reddit's r/Zepbound, one member described paying out of pocket for Zepbound while their formulary exception with CVS Caremark was being worked out, in a thread titled “Non formulary exception success”. The post does not identify the plan as GEHA, and one story doesn't predict your result.

What your doctor should send

Caremark's request form says that sending only basic patient and drug information “may not constitute a sufficient request.” Records matter. Bring your doctor this list, then match it to the criteria Caremark supplies: 4

• Every weight-loss medicine you've tried, with dates and why it didn't work or isn't safe. The form has blank lines for exactly this.
• Your Wegovy details: start and stop dates, the highest dose you reached, and your weight at the start and at each dose.
• Side effects: what happened, when, how bad, and what you tried to fix it.
• Your BMI and any weight-related conditions, backed by chart notes. The form asks whether chart notes were sent.
• Your weight-management history, including diet, activity, and follow-up visits. The general form asks about at least six months in a comprehensive program before treatment; confirm how GEHA applies that question to you.
• Recent Zepbound use, if any. The form asks whether you've taken the drug in the last 120 days. If you've been paying cash for Zepbound, keep those receipts. They can help document fills, but they do not replace clinical records or an applicable alternative-drug requirement.
• A sleep study, if sleep apnea is part of the request.

Already lost weight on another medicine? Bring your starting records, too. Caremark's public weight-management template distinguishes baseline BMI from current BMI, including when someone switches from another weight-loss drug. A lower BMI today does not erase the weight history your doctor needs to document. 15

Open the GEHA-linked exception and prior-authorization request form →

How long approval lasts, and how renewal works

Use the dates in your approval letter—not a blanket one-year rule. Caremark's public exception template lists 12 months. Its separate clinical template lists 8 months for initial weight-management approval, 6 months for initial sleep-apnea approval, and 12 months for continuation. These are template periods, not verified promises about your GEHA approval. 3 15

For weight-loss continuation, Caremark's general form asks whether you've had 3 months at a steady maintenance dose and lost at least 5% of your starting weight, or kept that loss off. Sleep-apnea continuation uses a different response check in the clinical template. Write down your weight every month, and keep follow-up records for the condition being treated. 4 15

Start renewal early. Before January 1, 2026, GEHA told members their doctors could begin the exception process before the plan change took effect. Ask when you can submit your next renewal; do not assume the same window or rules apply for 2027. 1

Who can file the exception for you?

You have two good options:

1. Your own doctor. This avoids a separate telehealth membership. An in-network primary care visit costs $30 on FEHB High and $10 on Elevate under the listed standard benefits. If your doctor already knows your Wegovy history, they have the records the exception needs. We earn nothing on this path, and it's often the right one. 6 9
2. A telehealth program with an insurance team, if your doctor won't file exceptions or you don't have one. Ask whether it will handle your specific GEHA formulary exception before paying.

An honest note about Ro before you click. Ro isn't the cheapest way to get Zepbound. Its membership is a separate charge on top of your medicine. If you already have a doctor willing to file your GEHA exception, use them and save the membership fee. But Ro puts a prescriber, a team that handles the insurance paperwork, and a cash-pay backup in one place. So if GEHA says no, you don't have to start over somewhere else. 18 19

Ro says FEHB members can use its insurance concierge. If a Ro provider prescribes Zepbound, Ro's team handles insurance paperwork, including prior authorization requests. Caremark uses one combined form for exceptions and prior authorizations, but that does not establish that every service handles both. Ro currently estimates 1–2 weeks for its insurance process; that is Ro's estimate, not a GEHA decision deadline. 4 19

"I was not expecting insurance help. Usually patients are their own advocate, so I was thrilled to not have to fight for my coverage." — Hannah, Ro member, featured on Ro's website. Ro states members were paid for their testimonials. One person's experience doesn't predict GEHA's decision.

Not sure yet? Start with the free part. Ro offers a free coverage report for the Zepbound pen. Its checker page also advertises a $50 treatment credit for new Ro accounts. The credit is a Ro offer, not cash or a guaranteed $50 reduction in your pharmacy bill. 20

Get a free GEHA coverage check from Ro → (sponsored)

Good to know: Ro's checker covers the Zepbound single-dose pen, not the Zepbound KwikPen. On Ro, the KwikPen is cash-pay only. The free report does not submit an exception or authorize treatment. GEHA makes the final coverage decision. 20 21

Before starting a paid membership: Ro advertises $39 for the first month, then $149 month-to-month, or as low as $74 per month with an annual plan paid upfront. Medication is billed separately. The membership renews automatically, including while you are not receiving medication. Ro's terms require cancellation at least 48 hours before renewal; paid fees are generally nonrefundable, with specific offers such as the first-month clinical-ineligibility refund described on its pricing page. The free checker is separate from this paid membership. 22 23

Does GEHA cover Zepbound for sleep apnea?

Zepbound is FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity. That gives your doctor a separate treatment purpose to document, but it does not guarantee GEHA coverage or establish which exception rules apply. Ask for GEHA's sleep-apnea criteria for your exact prescription. 16 17

The FDA approved Zepbound for obstructive sleep apnea (OSA, when your airway keeps closing during sleep) in December 2024. That matters for coverage, because it's a medical use that isn't about weight loss alone.

What helps a sleep-apnea request:

• A sleep study showing moderate-to-severe OSA. Caremark's public clinical template uses an apnea-hypopnea index, or AHI, of 15 or more—a measure of breathing problems per hour of sleep.
• Your current BMI. That template uses a current BMI of 30 or more for OSA.
• What you've already tried, such as a CPAP machine, and your prescriber's treatment plan. The public template does not make a failed CPAP trial a universal prerequisite. 15

Caremark's public exception template discusses both weight loss and OSA and asks about Wegovy. That is not proof that GEHA applies a Wegovy-trial rule to every OSA request. Have your doctor confirm the indication-specific policy instead of borrowing the weight-loss answer. 3

We can't promise GEHA will treat sleep apnea as enough to approve Zepbound. It's a real treatment indication, not a guaranteed coverage decision. And never change a diagnosis to get coverage. The request form makes your doctor attest that everything is true. 4

How much will Zepbound cost with GEHA if I'm approved?

The exact price requires your prescription's approved rate and pharmacy quote. GEHA publishes non-preferred brand rates, but its weight-loss FAQ does not say that every approved Zepbound exception uses those rates. Use the table below to check a quote—not as a guaranteed Zepbound price. 1 5

Non-formulary is not the same as non-preferred. One describes a drug's status on the list; the other is a cost-sharing category. Ask Caremark which category applies after your exception is approved.

What are GEHA's published non-preferred brand rates?

These are 2026 in-network, non-specialty rates when GEHA is primary, outside its Medicare prescription benefit. HDHP rates apply after the deductible. They apply to Zepbound only if Caremark confirms that your approved prescription uses this category.

Sources: GEHA's 2026 High, Standard, HDHP, Elevate, Elevate Plus, PSHB High, PSHB Standard, and PSHB HDHP benefit pages, checked September 22, 2026. High's maintenance-drug rule is explained in the FEHB and PSHB brochures. “No per-fill cap” does not mean there is no annual out-of-pocket limit.

Why "up to"? Coinsurance is a percentage of GEHA's allowed price. At the listed rates, High's $400 cap is reached at a $1,000 allowed price; Standard's $550 cap is reached at about $916.67. Those are calculated thresholds—not evidence that your prescription hits either cap. A manufacturer's list price cannot tell us GEHA's allowed price.

Do not count on a three-month fill until it's confirmed. Ask whether your exact product, dose, and quantity can be dispensed through the lower-cost channel. Lilly's self-pay “month” means 28 days, while GEHA lists up-to-30-day and up-to-90-day benefit categories. Compare the same number of weekly doses; do not treat 28 days as a calendar month. 10 24

High plan: watch the third-fill rule

On FEHB and PSHB High, the third and later retail fills of a maintenance drug outside Maintenance Choice cost the greater of 50% of the plan allowance or the usual listed cost share. The earlier $400 FEHB or $300 PSHB retail maximum does not cap that 50% charge. 10 31

For a monthly shot like Zepbound, ask early whether your prescription qualifies for Maintenance Choice through mail order or CVS pickup, and which days-supply rule applies. Do not switch to a larger supply without your prescriber's approval.

Elevate: check the rate before doing the paperwork

Elevate is the only GEHA FEHB plan where Wegovy remains preferred in GEHA's 2026 weight-loss FAQ. But on Elevate, non-preferred brands cost 100%, there's no mail order, and the pharmacy network is limited. Before you file an exception on Elevate, ask Caremark which rate an approved Zepbound would use. An exception does not, by itself, establish a dollar contribution from the plan. 1 9

HDHP: deductible first

On HDHP, you pay the allowed cost subject to your remaining deductible, then the applicable coinsurance. At the listed non-preferred rate, that is 40% with no per-fill cap. The cost tool shows the after-deductible price. Ask for a quote that uses your remaining deductible today, not just the post-deductible estimate. 5 8 14

Can I use the Zepbound savings card with GEHA?

Do not count on a savings card until Lilly confirms your eligibility and the pharmacy confirms the claim. Lilly excludes governmental beneficiaries under its terms. FEHB's absence from the examples does not establish that your exact coverage qualifies. A legal definition from another program does not settle Lilly's offer terms. 25

For eligible commercially insured patients whose plan covers the single-dose pen, the card offers up to $100 off 28 days, $200 off 56 days, or $300 off 84 days, subject to the program's minimum payment and limits. The annual maximum is $1,300, with up to 13 fills, through December 31, 2026. “As little as $25” is not a guaranteed $25 GEHA copay. 25

Lilly also lists a separate $499-per-28-day single-dose-pen offer for eligible commercially insured patients without coverage. So savings-card help is not limited to people with an approved exception. KwikPen and vial self-pay offers have separate terms. 25

Use this check: first get your insurance price without a card. Then ask the pharmacy what you would pay with the specific card you qualify for. Compare that final amount with self-pay. More details: Zepbound savings card guide.

Is it cheaper to pay cash for Zepbound than to use GEHA?

Sometimes—but compare your actual approved price, not just a plan's maximum. LillyDirect lists Zepbound KwikPen and single-dose vial self-pay prices of $299 for 2.5 mg, $399 for 5 mg, and $449 for higher doses under its offer. The higher-dose price requires timely refills after the first purchase. 24

We lined up every GEHA plan against Lilly's cash price. The comparison below uses $449 for four weekly doses, the offer price for 10 mg and 15 mg weight-management maintenance doses. 5 mg is also a maintenance dose and costs $399 under the listed self-pay offer. The 2.5 mg dose is a starting dose; 7.5 mg and 12.5 mg are not labeled maintenance doses. 16 24

What does the insurance-versus-cash math actually show?

These are conditional examples, not member price quotes. They assume Caremark confirms the non-preferred rate, no deductible remains where relevant, and the same number of doses can be filled under the listed benefit. No savings card, care fee, supplies, or annual out-of-pocket limit is included.

How we did the math: for capped plans, we compared the cap to $449. For plans with no per-fill cap, we divided $449 by the listed percentage to find the break-even allowed price. For a three-pack comparison, we divided the total by three. That comparison applies only when Caremark confirms that a 12-dose, 84-day prescription qualifies for the listed up-to-90-day benefit and is available through that channel.

What the table tells you:

1. On GEHA Standard, a hard-won exception can cost more than cash at a retail pharmacy. It does so in the $550 example—not for every member. A qualifying mail fill or confirmed savings offer can change the answer.
2. On Elevate, get the dollar quote before choosing cash. Paying 100% does not tell you whether the allowed price is above or below $449.
3. Check again at each prescribed dose. A $299 starter fill, a $399 5 mg fill, and a $449 higher-dose fill have different break-even points. Do not assume everyone moves up after the same number of months.

One trade-off: eligible covered spending through GEHA can count toward your yearly out-of-pocket maximum. GEHA lists Self Only in-network maximums of $7,500 on FEHB High and $10,600 on Elevate. 6 9 Cash outside the plan generally does not. Non-covered drugs and certain penalties do not count either. If you have big medical bills this year, that can tip the math. Ask what the specific claim—not just the drug name—would count toward your limit. 10 31

Legit ways to buy brand-name Zepbound without GEHA

Lilly lists single-dose vials through its LillyDirect self-pay program, with delivery and participating Walmart pickup options. KwikPen has additional pharmacy options, and Lilly lists some insurance access for it. Ro's cash-only KwikPen policy is not a rule for every pharmacy or every insurance plan. 24

Every option here supplies or covers brand-name, FDA-approved Zepbound made by Eli Lilly. We don't list compounded tirzepatide on this page.

Check both bills, not just the drug price. A $449 medication fill plus a $149 Ro membership charge is $598 when both charges are due, before any extra supplies or fees. The medication's 28-day supply and the membership's billing cycle are not the same thing. Using your own prescriber with LillyDirect avoids Ro's membership fee. 21 22

Paying with HSA or FSA money: LillyDirect lists Zepbound as HSA/FSA eligible and notes that eligibility may vary by plan. Check with your HSA custodian or FSAFEDS before you pay. 24

Does cash make more sense on your plan? Once you've compared your actual quote, you can choose a cash-pay path without waiting for GEHA's approval. A Ro provider can check whether Zepbound fits you, and Ro lists the KwikPen at Lilly's dose-based self-pay prices, plus its membership fee. 21

See if you qualify for Zepbound on Ro → (sponsored)

Get started for $39, then as low as $74/month with annual plan paid upfront, or $149 month-to-month. Medication is billed separately. Prescribed only if appropriate.

Will GEHA cover Zepbound after October 1, 2026, or in 2027?

Do not assume CVS Caremark's October 1 change automatically changes your GEHA benefit. CVS announced Zepbound's return as a preferred option on its commercial formularies, but plan sponsors can customize coverage. We did not verify a GEHA-specific adoption of that change in the documents checked on September 22, 2026. 32

What CVS announced for October 1

On May 28, 2026, CVS Health said Zepbound will return to its commercial formularies as “an additional preferred option” on October 1, 2026. The same announcement says plan sponsors retain discretion to customize coverage. 32

GEHA links different drug lists for its plan groups, including a CVS Value Formulary for Elevate. That is why the right question is not whether GEHA uses CVS—it does—but whether your exact GEHA benefit adopted this change. 2

Call Caremark in October and ask. For the broader Caremark story, see Does CVS Caremark cover Zepbound?

Don't stop or delay treatment you need while you wait for October. A headline isn't a coverage decision. Discuss any treatment change with your prescriber.

What OPM changed for 2027

The Office of Personnel Management (OPM) runs the FEHB program. Its 2027 guidance to plans—Carrier Letter 2026-07, March 31, 2026—keeps the requirement for at least one GLP-1 anti-obesity medication for weight loss, plus at least two additional oral weight-loss drugs. It does not require every plan to make Zepbound preferred. 33

The letter also calls for prior authorization to confirm past and continuing participation in lifestyle care meeting the standard of intensive behavioral therapy, or IBT. That means structured work on nutrition, activity, and behavior change. A statement that someone tried to lose weight is not, by itself, enough to bypass those requirements. 33

In plain English: for 2027, ask what records your plan needs to show you're taking part in the required program before and during treatment.

Should you switch plans at Open Season to get Zepbound?

Compare both coverage and cost—not just the drug's name on a list. In 2026, Zepbound has the same non-formulary status across GEHA's five FEHB plans, but their cost-sharing rules differ. A switch can change costs without removing an exception requirement. GEHA's 2027 Zepbound status was not established by the documents reviewed for this page. 1 6 7

Federal Benefits Open Season runs November 9–December 14, 2026. Compare each carrier's 2027 drug list when available, and read Section 2 of its brochure for benefit changes. Our FEHB Zepbound coverage guide explains the broader comparison. Don't pick a health plan for one drug alone. 34

What should I ask GEHA or Caremark before I pay?

Ask six questions before you pay for any Zepbound prescription: which drug list applies, whether you have an approval, which criteria apply, what the actual fill costs, what treatment records count, and where to get the answer in writing. These answers let you compare insurance and cash without guessing.

Who to call:

• CVS Caremark for GEHA members: 1-844-443-4279. 1
• GEHA Customer Care: 1-800-821-6136. 2
• GEHA FedViser, for plan-choice questions: 1-833-973-4342. 6

Your call script:

1. "Is Zepbound on my plan's drug list today, and does that change on October 1, 2026?" 2. "Do I have an active approval on file for Zepbound? When does it end?" 3. "What criteria does GEHA use for a Zepbound exception? Do I need to have tried Wegovy? Which rules apply to my treatment purpose?" 4. "If I'm approved, what tier is it billed at, and what exactly do I pay for my product, dose, and pharmacy? Please compare four doses with a twelve-dose fill, explain any maintenance-drug penalty, and use my remaining deductible." 5. "Does a Wegovy trial I paid for myself count, or does it have to be on my GEHA claims?" 6. "Can I get a reference number and the written policy for these answers?"

Write down the date, the name of the person you spoke with, and the reference number. Keep the written benefit terms and any approval or denial notice with your notes.

Your copy-and-save comparison sheet

Copy this into your notes or print it. No insurance-card upload or email signup is needed.

Your decision rule: compare the amount you would actually pay for the same prescribed supply, then account for care fees and any value from meeting your plan's annual limit. Keep medical suitability separate from the price decision.

What if GEHA denies my Zepbound exception?

You can ask for review. Start with your denial letter: it says why you were denied and where to send the response. Under the regular FEHB disputed-claims process, the written request for GEHA to reconsider is generally due within six months. Medicare drug appeals follow a separate process. 10 27

The regular FEHB appeal path:

1. Ask for reconsideration. The FEHB brochure calls this a written appeal asking the plan to reconsider its decision. File within six months, using the instructions for your claim. Do not assume you must complete two separate GEHA appeals before requesting OPM review.
2. Request OPM review when eligible. After GEHA upholds its decision, the usual deadline is 90 days from that letter. Different deadlines apply when the plan has not responded; Section 8 of the brochure explains them.
3. Watch for the response. OPM's stated 60-day step can be a decision or a status update, not necessarily a final decision. 10

For urgent treatment needs, ask your prescriber and the plan about expedited review rather than relying on the ordinary schedule.

Where to send it: Follow your denial letter first, because pharmacy denials may come from CVS Caremark. For requests that the letter directs to GEHA's pre-service appeals unit, GEHA lists G.E.H.A., P.O. Box 400046, San Antonio, TX 78229, fax 1-866-963-0156, and forms at geha.com/Appeals. Do not send a Caremark pharmacy appeal to that general address unless your notice directs you there. Someone else can appeal for you with GEHA's Designation of Authorized Representative form. 27

If an OPM decision remains disputed, the FEHB brochure describes judicial review against OPM in federal court, generally no later than December 31 of the third year after the year of the disputed service or preauthorization denial. That is a legal step; use the applicable brochure and legal advice for your case. 10

Match your appeal to the reason. A missing-records denial needs those records. A denial based on the criteria needs your doctor's explanation of how the request meets them. Use this fill-in template with your doctor:

"The denial says ____. The records that answer that reason are ____. My doctor's explanation is ____. The deadline and address in my letter are ____."

While you wait: ask your prescriber about a safe plan for continuing care. Brand-name Zepbound self-pay options start at $299 for the starter dose, with dose-based prices and refill terms. See cash options above. 24

I have Medicare. Does GEHA cover Zepbound for me?

It depends on where your drug coverage comes from. GEHA's SilverScript Medicare prescription benefit is available to eligible PSHB retirees and eligible FEHB High or Standard retirees—not just postal retirees. Check the prescription card you actually use before applying the regular FEHB rules or cost table. 28

Can the Medicare GLP-1 Bridge lower the cost to $50?

The Bridge runs July 1, 2026–December 31, 2027 and charges eligible members $50 per monthly supply. It operates outside the normal Part D payment flow. For Zepbound, it includes KwikPen only, not the single-dose pen or vial. 26

Your prescriber must submit prior authorization. You must be at least 18, enrolled in an eligible Part D plan type, and using the medication for weight management alongside structured nutrition and physical activity. CMS uses your BMI when GLP-1 treatment began, not simply today's BMI. 35

CMS defines uncontrolled high blood pressure here as systolic pressure above 140 or diastolic pressure above 90 despite treatment with two blood-pressure medicines. The table is only the clinical part of eligibility. 35

The catches worth checking before you make plans:

• A Part D-covered treatment purpose comes first. CMS excludes people with type 2 diabetes, moderate-to-severe OSA, or noncirrhotic MASH with moderate-to-advanced liver scarring from this Bridge pathway. Those conditions use regular Part D coverage rules—even when the person's plan denies the requested drug. 26
• Prior 2026 GLP-1 fills can block 2026 Bridge access. CMS includes fills paid through Part D and supplemental coverage in an employer group plan, or EGWP, in that review. 26
• The $50 does not count toward your Part D out-of-pocket limit. Coupons cannot be used with it. 36

Your next step: ask your prescriber to review the CMS provider instructions and submit the Bridge request when appropriate. The prescriber help line is 855-273-0102. For member questions, call 1-800-MEDICARE (1-800-633-4227). This is not a reason to switch insurance or assume a retail coupon applies. 35

More detail: our Medicare GLP-1 Bridge guide.

I have type 2 diabetes. Is Mounjaro the same as Zepbound?

Mounjaro and Zepbound contain the same active ingredient, tirzepatide, but they are FDA-approved for different uses. Mounjaro treats type 2 diabetes. Zepbound treats weight management and obstructive sleep apnea. If you have type 2 diabetes, ask your doctor which fits you, because diabetes drugs follow different coverage rules. 16 37

Mounjaro's current label also includes reducing major cardiovascular events in adults with type 2 diabetes who are at high cardiovascular risk. That does not make a Mounjaro prescription interchangeable with a Zepbound prescription for insurance. 37

Look up Mounjaro separately in GEHA's cost tool. Its status and price can be different from Zepbound's. Your doctor decides which medicine fits your diagnosis.

What should I know about Zepbound safety before I start?

Zepbound carries an FDA boxed warning about thyroid C-cell tumors seen in rodent studies, and it should not be used by people with a personal or family history of medullary thyroid cancer or MEN 2. It is not known whether it causes these tumors in humans. Coverage approval is not the same as medical suitability. 16

A few label facts worth knowing before your first dose:

• Common side effects include nausea, diarrhea, vomiting, and constipation, often while your dose is going up.
• Don't combine it with other tirzepatide products or other GLP-1 medicines.
• Birth control pills: switch to a non-oral method, or add a barrier method, for 4 weeks after you start and after each dose increase.
• Pregnancy or serious allergy: contact your prescriber and stop Zepbound if you become pregnant. Do not use it after a serious allergic reaction to tirzepatide or its ingredients.
• Get urgent help for severe symptoms. Trouble breathing or swelling of the face or throat needs emergency care. Severe, lasting stomach pain needs prompt medical attention. 16 38

Read the full Zepbound prescribing information and Medication Guide and talk through your history with your prescriber. This coverage guide does not replace medical advice.

How we checked this

On September 22, 2026, we checked GEHA's coverage FAQ, plan and cost-tool pages, Caremark's public criteria and request form, Lilly's prices and savings terms, Ro's pricing and service terms, CVS's October announcement, OPM's 2027 letter, CMS's Bridge rules, and GEHA's appeals documents. We did not access a member's account, call an insurer, obtain a personal pharmacy quote, or file a real request.

What we actually verified GEHA: the five FEHB plans' published 2025–2026 weight-loss status, the reason the cost tool lists Zepbound, the listed prescription cost shares, High's maintenance-drug rule, and the regular FEHB appeal process. Caremark: what its public exception template, clinical template, and GEHA-linked general request form say—not that GEHA applies every template provision to every member. Lilly and Ro: the public prices, offer conditions, service descriptions, and billing terms linked below—not a completed purchase or insurance outcome. FDA, OPM, and CMS: the current prescribing information and the specific published rules described on this page. Not confirmed: your approval, the cost-sharing category for your approved exception, your pharmacy's final price, your savings-card eligibility, GEHA's adoption of the October 1 change, or GEHA's 2027 Zepbound status.

What do the provider claims prove—and what don't they prove?

How we built the tables: We kept GEHA's drug status separate from its cost-sharing categories, then compared conditional plan-rate examples with Lilly's prices. The break-even numbers are simple math you can repeat. They are not a study of member claims, an approval predictor, or a substitute for your own quote.

How this page fits our scoring: The RX Index Score rates providers and treatment paths on five pillars: clinical legitimacy, care quality, transparency, access, and cost. On this page, only FDA-approved, brand-name Zepbound paths are listed, including the option to use your own prescriber without paying a separate telehealth membership.

Frequently asked questions

Does GEHA Standard cover Zepbound?

For weight loss under the regular 2026 FEHB benefit, only with an approved formulary exception. Standard's published non-preferred rates are 60%, up to $550 retail or $1,100 for up to 90 days by mail. Those are not confirmed Zepbound exception prices. Ask Caremark which rate your approval uses. 1 7

Does GEHA High cover Zepbound?

Only with an approved exception under the regular FEHB weight-loss rules. If the non-preferred rate applies, the listed retail maximum is $400 before the maintenance-drug third-fill rule, or $800 for qualifying mail service. The third-and-later retail maintenance charge can exceed the earlier cap. 1 10

Does GEHA Elevate cover Zepbound?

An approved exception is required. Non-preferred brands cost 100% on Elevate, and the plan has no mail order. Ask Caremark which rate an approved Zepbound uses before filing. 1 9

Does GEHA HDHP cover Zepbound?

An approved exception is required under the regular FEHB weight-loss rules. The published non-preferred rate is 40% after the deductible, with no per-fill cap. Confirm that rate applies to your exception and ask for a quote using your remaining deductible. 1 8

Does GEHA require prior authorization for Zepbound?

GEHA requires a formulary exception for weight-loss coverage, and clinical authorization requirements can also apply. Caremark uses one combined Formulary Exception/Prior Authorization Request Form for both. 2 4

Do I have to try Wegovy before GEHA covers Zepbound?

Caremark's public exception template calls for inadequate response, intolerance, or a contraindication to Wegovy. A contraindication can be documented without taking an unsafe drug. Confirm that GEHA uses this rule for your plan and treatment purpose; we did not verify universal adoption of that template. 3

How long does a GEHA Zepbound approval last?

Use your approval letter. The public exception template lists 12 months, but the separate clinical template has different initial approval periods. Do not assume one approval date covers every required review. 3 15

Does GEHA cover Zepbound vials or KwikPen?

Do not assume a pen approval covers every presentation. Caremark's public exception template excludes vials; its clinical template excludes vials and KwikPen. Those template exclusions are not a verified GEHA-specific decision. Ask about the exact product code on your prescription. LillyDirect lists single-dose vials for self-pay, while KwikPen has self-pay and some insurance access outside Ro. 3 15 24

Does GEHA cover Wegovy?

GEHA's 2026 FEHB FAQ lists Wegovy with prior authorization on all five plans. It is non-preferred on four and preferred on Elevate. See Does GEHA Cover Wegovy? for that separate coverage question. 1

Is Zepbound coming back to GEHA on October 1, 2026?

CVS announced a preferred-formulary change, but we did not verify a GEHA-specific change in the documents checked on September 22, 2026. Ask for your plan's written rule and effective date. 32

Can I use the Zepbound savings card with GEHA?

Your exact eligibility needs confirmation under Lilly's terms. Do not assume FEHB qualifies because it is not named in the examples of excluded coverage. Get your prescription price without the card first, then have the pharmacy check the specific offer. 25

Can teenagers get Zepbound through GEHA?

Zepbound is FDA-approved for adults. It is not approved for children or teens. Its prescribing information says safety and effectiveness in pediatric patients have not been established. 16

Still not sure which GLP-1 program is right for you? Use our free Find My GLP-1 Path tool.

Sources

Public sources below were checked September 22, 2026. A source-check date does not mean the plan or provider issued a new policy that day.

1. GEHA: Pharmacy coverage for weight loss GLP-1 medications, FE-WEB-1225-001.
2. GEHA: Prescription drug benefits overview and current document links.
3. CVS Caremark: Zepbound exception template 7056-A, P07-2025 v2.
4. CVS Caremark: Formulary Exception/Prior Authorization Request Form 106-37207A, linked by GEHA.
5. GEHA: Check Drug Costs, including the HDHP estimate note.
6. GEHA: 2026 FEHB High benefits.
7. GEHA: 2026 FEHB Standard benefits.
8. GEHA: 2026 FEHB HDHP benefits.
9. GEHA: 2026 FEHB Elevate benefits.
10. GEHA: 2026 FEHB High and Standard brochure, Sections 4, 5(f), and 8.
11. GEHA: 2026 FEHB Elevate Plus benefits.
12. GEHA: 2026 PSHB High benefits.
13. GEHA: 2026 PSHB Standard benefits.
14. GEHA: 2026 PSHB HDHP benefits.
15. CVS Caremark: Tirzepatide clinical prior-authorization template 6947-C.
16. Eli Lilly: Zepbound prescribing information, revised August 2026.
17. FDA: Zepbound approval for obstructive sleep apnea, December 20, 2024.
18. Ro: Weight-loss program and paid-testimonial disclosure.
19. Ro: Insurance support, FEHB access, and estimated processing time.
20. Ro: GLP-1 Insurance Coverage Checker and limitations.
21. Ro: Zepbound options and dose-based prices.
22. Ro: Membership pricing and introductory-offer conditions.
23. Ro: Terms of Use, including Ro Body cancellation and renewal.
24. Eli Lilly: LillyDirect Zepbound prices, product options, and self-pay terms.
25. Eli Lilly: Zepbound savings terms and eligibility.
26. CMS: Medicare GLP-1 Bridge information for Part D plans.
27. GEHA: Appeal Process and Disputed Claims FAQs.
28. GEHA: Medicare prescription drug plan and eligibility.
29. Aronne et al.: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity, NEJM 2025; PubMed record.
30. Reddit: “Non formulary exception success,” used only as an individual account—not coverage evidence.
31. GEHA: 2026 PSHB High and Standard brochure, prescription benefits.
32. CVS Health: May 28, 2026 announcement of the October 1 formulary change.
33. OPM: Carrier Letter 2026-07, March 31, 2026, obesity-benefit requirements.
34. U.S. Department of Veterans Affairs: 2026 Federal Benefits Open Season dates.
35. CMS: Medicare GLP-1 Bridge information for providers.
36. CMS: Medicare GLP-1 Bridge information for pharmacies.
37. Eli Lilly: Mounjaro prescribing information, revised August 2026.
38. Eli Lilly: Zepbound Medication Guide.